These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 30794951)

  • 1. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
    Toutounji M; Tokajian S; Khalaf RA
    Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
    Fattouh N; Hdayed D; Geukgeuzian G; Tokajian S; Khalaf RA
    Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.
    Ben-Ami R; Garcia-Effron G; Lewis RE; Gamarra S; Leventakos K; Perlin DS; Kontoyiannis DP
    J Infect Dis; 2011 Aug; 204(4):626-35. PubMed ID: 21791665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.
    Lee KK; Maccallum DM; Jacobsen MD; Walker LA; Odds FC; Gow NA; Munro CA
    Antimicrob Agents Chemother; 2012 Jan; 56(1):208-17. PubMed ID: 21986821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UPC2 mutations and development of azole resistance in Candida albicans hospital isolates from Lebanon.
    Fattouh N; Hdayed D; Hijazi A; Tokajian S; Khalaf RA
    J Glob Antimicrob Resist; 2024 Sep; 38():341-348. PubMed ID: 39059553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans.
    Wiederhold NP; Najvar LK; Bocanegra RA; Kirkpatrick WR; Patterson TF
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3254-60. PubMed ID: 21502632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
    Lackner M; Tscherner M; Schaller M; Kuchler K; Mair C; Sartori B; Istel F; Arendrup MC; Lass-Flörl C
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin.
    Imtiaz T; Lee KK; Munro CA; MacCallum DM; Shankland GS; Johnson EM; MacGregor MS; Bal AM
    J Med Microbiol; 2012 Sep; 61(Pt 9):1330-1334. PubMed ID: 22653922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.
    Walraven CJ; Bernardo SM; Wiederhold NP; Lee SA
    Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated chitin content reduces the susceptibility of Candida species to caspofungin.
    Walker LA; Gow NA; Munro CA
    Antimicrob Agents Chemother; 2013 Jan; 57(1):146-54. PubMed ID: 23089748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.
    Angiolella L; Stringaro AR; De Bernardis F; Posteraro B; Bonito M; Toccacieli L; Torosantucci A; Colone M; Sanguinetti M; Cassone A; Palamara AT
    Antimicrob Agents Chemother; 2008 Mar; 52(3):927-36. PubMed ID: 18180350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 15. Adhesive and biofilm-forming Candida glabrata Lebanese hospital isolates harbour mutations in subtelomeric silencers and adhesins.
    Fattouh N; Husni R; Finianos M; Bitar I; Khalaf RA
    Mycoses; 2024 Jun; 67(6):e13750. PubMed ID: 38813959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection.
    Shields RK; Nguyen MH; Press EG; Cumbie R; Driscoll E; Pasculle AW; Clancy CJ
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7465-70. PubMed ID: 26392494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Candida albicans to common and novel antifungal drugs, and relationship between the mating type locus and resistance, in Lebanese hospital isolates.
    Basma R; Barada G; Ojaimi N; Khalaf RA
    Mycoses; 2009 Mar; 52(2):141-8. PubMed ID: 18627469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis.
    Hassoun Y; Aptekmann AA; Keniya MV; Gomez RY; Alayo N; Novi G; Quinteros C; Kaya F; Zimmerman M; Caceres DH; Chow NA; Perlin DS; Shor E
    PLoS Pathog; 2024 Sep; 20(9):e1012521. PubMed ID: 39250486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Sap prevalence and biofilm formation among resistant clinical isolates of
    Kadry AA; El-Ganiny AM; El-Baz AM
    Afr Health Sci; 2018 Dec; 18(4):1166-1174. PubMed ID: 30766582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.
    Perrine-Walker F
    Braz J Microbiol; 2022 Sep; 53(3):1101-1113. PubMed ID: 35352319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.